Allspring Global Investments
STLN

Allspring Global Investments’s Starling Oncology STLN Stock Holding History

Allspring Global Investments’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$278K Buy
+51,282
New +$215K ﹤0.01% 1592
2023
Q2 		– Sell
-35,744
Closed -$24.2K – 2835
2023
Q1 		$24.2K Buy
35,744
+25,059
+235% +$32K ﹤0.01% 2467
2022
Q4 		$17.6K Sell
10,685
-234
-2% -$657 ﹤0.01% 2616
2022
Q3 		$50K Buy
+10,919
New +$64.2K ﹤0.01% 2358

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Allspring Global Investments's STLN Position: Q2 2026 in Review

Allspring Global Investments opened a new position in Starling Oncology (STLN) in Q2 2026: 51,282 shares worth $278K. The stake represents ﹤0.01% of the portfolio and ranks #1592 among its holdings. This is a return to the name: Allspring Global Investments previously reported a position in STLN as recently as Q1 2023.

Allspring Global Investments first reported a position in STLN in Q3 2022 and has held it in 4 quarters since. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • Allspring Global Investments held 51,282 shares of Starling Oncology worth $278K as of Q2 2026.
  • Starling Oncology was a new Allspring Global Investments position in Q2 2026.
  • Starling Oncology made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1592 holding.
  • Allspring Global Investments first reported a position in Starling Oncology in Q3 2022 and has held it in 4 quarters since.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.